GMP – Page 68 – Pharma.Tips

Inadequate WHO GMP training during internal gap assessment – CAPA aligned to WHO standards

Addressing Insufficient WHO GMP Training in Internal Gap Assessments In the complex landscape of pharmaceutical manufacturing, ensuring compliance with WHO GMP standards is critical. Inadequate training during internal gap assessments…

API site WHO GMP risk during WHO inspection – avoiding repeat WHO observations

Mitigating API Site Risks During WHO Inspections: A Practical Playbook Pharmaceutical manufacturers face a growing imperative to maintain compliance with WHO Good Manufacturing Practice (GMP) standards. The increasing scrutiny during…

Inefficient CIP cycle during validation lifecycle – inspection-ready cleaning optimization

Addressing Challenges in CIP Cycle Inefficiencies During the Validation Lifecycle As pharmaceutical manufacturing processes continuously evolve, the demand for effective and efficient cleaning processes is emphasized, especially during the validation…

Repeated GMP deviations during internal audit – evidence package for inspection defense

Addressing Persistent GMP Deviations During Internal Audits: A Playbook for Compliance In the complex world of pharmaceutical manufacturing, repeated GMP deviations during internal audits can threaten product quality, regulatory standing,…

Uncontrolled SOP changes during scale-up – FDA/EMA inspection citation risk

Managing Uncontrolled SOP Changes During Scale-Up to Mitigate FDA/EMA Inspection Risks Uncontrolled changes to Standard Operating Procedures (SOPs) during scale-up can lead to significant compliance risks, resulting in potential citations…

Inadequate GMP training during scale-up – CAPA framework to prevent recurrence

Preventing Recurrences of Inadequate GMP Training During Scale-Up: A Comprehensive Playbook In the dynamic landscape of pharmaceutical manufacturing, inadequate GMP training during the scale-up phase can jeopardize both product quality…

Redundant cleaning steps during validation lifecycle – validated efficiency improvement

Improving Efficiency by Reducing Redundant Cleaning Steps in the Validation Lifecycle Pharmaceutical manufacturers often encounter challenges with redundant cleaning steps during equipment validation, which can lead to increased cycle times…

Inconsistent GMP interpretation during regulatory inspection – FDA/EMA inspection citation risk

“`html Strategies for Managing Inconsistent GMP Interpretation during Regulatory Inspections In the pharmaceutical manufacturing sector, inconsistent interpretations of Good Manufacturing Practices (GMP) during regulatory inspections can lead to serious risks,…

Uncontrolled SOP changes during scale-up – how to rebuild GMP maturity

Addressing Uncontrolled SOP Changes During Scale-Up to Enhance GMP Maturity In the highly regulated pharmaceutical environment, uncontrolled changes to Standard Operating Procedures (SOPs) during the scale-up phase can jeopardize both…

Poor change control discipline during routine manufacturing – FDA/EMA inspection citation risk

“`html Understanding and Addressing Poor Change Control in Routine Manufacturing In the pharmaceutical manufacturing industry, maintaining rigorous change control processes is essential to ensuring compliance with Good Manufacturing Practices (GMP).…

Manual cleaning variability during equipment changeover – validated efficiency improvement

Improving Equipment Changeover Efficiency: Addressing Manual Cleaning Variability In the rapidly advancing field of pharmaceutical manufacturing, manual cleaning variability during equipment changeover presents a frequent challenge, leading to increased downtime,…

Poor change control discipline during routine manufacturing – root cause analysis inspectors expect

Resolving Poor Change Control Discipline in Routine Manufacturing: An Actionable Playbook In today’s highly regulated pharmaceutical environment, maintaining strict change control procedures is vital to ensure product quality and compliance…